To develop potential treatments against osteonecrosis brought on by infectious osteomyelitis and treatment with anti-resorptive agents, we administered etanercept, a TNFα-inhibitor, subcutaneously one week before surgery and subsequently twice a week to alendronate-treated model mice infected in the left femur with SA (Fig. 5). The gene discussed is TNF; the disease is osteonecrosis.